Abstracts
Showing 807 abstracts.
Safety and Efficacy of Raltegravir (RAL) in Pediatric HIV Infection. Preliminary analysis from IMPAACT P1066
Conference
16th Conference on Retroviruses & Opportunistic Infections
Study
P1066
Authors
Andrew A. Wiznia, Pearl Samson, Edward P. Acosta, Hedy Teppler, Barney S. Graham, Terence Fenton, Edward Handelsman, Carol J. Worrell, Sharon Appelbaum NachmanPredictors of nevirapine resistance in Ugandan infants who were HIV-infected despite single dose nevirapine prophylaxis
Conference
16th Conference on Retroviruses & Opportunistic Infections
Authors
Jessica D. Church, Anthony Mwatha, Laura A. Guay, M. Thigpen, Philippa Musoke, C. Eure, M. McConnell, Mary Glenn Fowler, Brooks Jackson, Susan H. EshlemanA Phase II Study of the Incidence of Nevirapine Resistance Mutations (NR) in HIV-Infected Thai Women Receiving a Single Intrapartum (IP) Dose of NVP (SDNVP) Followed by a Postpartum (PP) Tail of ZDV/ddI or ZDV/ddI/LPV/r (PACTG/IMPAACT P1032)
Conference
16th Conference on Retroviruses & Opportunistic Infections
Study
P1032
Authors
Russell B. Van Dyke, Gonzague A. Jourdain, Nicole Ngo-Giang-Huong, Lisa M. Frenkel, Paula Britto, Anuvat Roongpisuthipong, Prapap Yuthavisuthi, Sinart Prommas, Thanyawee PuthanakitPrimary Isoniazid prophylaxis did not protect against Tuberculosis or Latent TB infection in HIV-exposed, uninfected infants in South Africa
Conference
16th Conference on Retroviruses & Opportunistic Infections
Study
P1041
Authors
Charles Debeaux Mitchell, George D. McSherry, Avy Violari, Mark F. Cotton, Raziya Bobat, Patrick Jean-Philippe, Sue Kim, Sharon Appelbaum NachmanSingle Dose Tenofovir Disoproxil Fumarate (TDF) with and without Emtricitabine (FTC) in HIV-1 Infected Pregnant Women and their Infants: Pharmacokinetics (PK) and Safety
Conference
16th Conference on Retroviruses & Opportunistic Infections
Authors
Patricia M. Flynn, Mark Mirochnick, David E. Shapiro, Arlene D. Bardeguez, Alice Huang, Susan A. Fiscus, Koen Van Rompay, James F. Rooney, Lynne M. Mofenson, Heather D. Watts, Patrick Jean-PhilippeA Novel Chewable Pediatric Fixed-Dose Combination (FDC) of Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP): Pharmacokinetics and Safety in HIV-Infected Thai Children
Conference
16th Conference on Retroviruses & Opportunistic Infections
Study
P1056
Authors
Nirun Vanprapar, Tim Roy Cressey, Kulkanya Chokephaibulkit, Edmund Capparelli, Virat Sirisanthana, Suchat Hongsiriwon, Kenneth McIntosh, Wasana Prasitsuebsai, Petronella Muresan, Ram YogevEarly Suppression of Viral Replication Preserves Measles-Specific Memory B Cells in Children
Conference
16th Conference on Retroviruses & Opportunistic Infections
Authors
Nishaki Mehta, Margaret McManus, Robert Lin, Mohan Somasundaran, Ram Yogev, Ellen Gould Chadwick, Katherine LuzuriagaIncreased Resistance to Lamivudine Detected in HIV-Positive Pregnant Women Discontinuing Zidovudine (AZT), Lamivudine (3TC), and Nelfinavir (NFV): Results of PACTG 1022
Conference
16th Conference on Retroviruses & Opportunistic Infections
Study
P1022
Authors
G. M. Ellis, Jane Hitti, L. FrenkelCryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes
Conference
16th Conference on Retroviruses & Opportunistic Infections
Authors
Donald Campbell, Nancy Tustin, Eric Riedel, Richard Tustin, J. Taylor, Steven D. DouglasPharmacokinetics (PK) of Tenofovir Disoproxil Fumarate (TDF) After Administration to HIV-1 Infected Pregnant Women and their Newborns
Conference
16th Conference on Retroviruses & Opportunistic Infections